Literature DB >> 33825166

Placental Lesions and Pregnancy Outcome in Anterior as Compared to Posterior Placenta Previa.

Daniel Tairy1, Eran Weiner2, Letizia Schreiber3, Hadas Miremberg2, Liat Gindes2, Roni Hochman2, Jacob Bar2, Michal Kovo2.   

Abstract

The uterine location of placenta previa (PP), anterior vs. posterior has an impact on pregnancy outcome. We aimed to study maternal and neonatal outcome and placental histopathology lesions in anterior vs. posterior PP. The medical records and histopathology reports of all singleton cesarean deliveries (CD) performed due to PP, from 24 to 41 weeks, between 12.2008 and 10.2018, were reviewed. Placental lesions were classified into maternal and fetal vascular malperfusion lesions (MVM, FVM), maternal and fetal inflammatory responses (MIR, FIR). Gestational age (GA) at delivery was similar between the anterior PP (n = 67) and posterior PP (n = 105) groups. As compared to the posterior PP group, the anterior PP group had higher rate of previous CD (p < 0.001), placental accreta spectrum (p = 0.04), lower neonatal Hb at birth (p = 0.03), higher rate of neonatal blood transfusion (p = 0.007) and prolonged maternal hospitalization (p = 0.02). Placentas from the anterior PP group had lower weights (p = 0.035), with increased rate of MVM lesions (p = 0.017). The anterior PP location is associated with increased adverse maternal and neonatal outcome, lower placental weights and increased rate of malperfusion lesions. Abnormal placentation in the scarred uterine wall probably has an impact on placental function.
© 2021. Society for Reproductive Investigation.

Entities:  

Keywords:  Anterior placenta previa; Maternal outcome; Neonatal outcome; Placental histopathology; Posterior placenta previa

Mesh:

Year:  2021        PMID: 33825166     DOI: 10.1007/s43032-021-00558-7

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   2.924


  22 in total

1.  The association between umbilical cord abnormalities and the development of non-reassuring fetal heart rate leading to emergent cesarean deliveries.

Authors:  E Weiner; N Fainstein; L Schreiber; R Sagiv; J Bar; M Kovo
Journal:  J Perinatol       Date:  2015-08-20       Impact factor: 2.521

2.  Placental diagnostic criteria and clinical correlation--a workshop report.

Authors:  R W Redline; D Heller; S Keating; J Kingdom
Journal:  Placenta       Date:  2005-04       Impact factor: 3.481

3.  Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis.

Authors:  Eric Jauniaux; Catey Bunce; Lene Grønbeck; Jens Langhoff-Roos
Journal:  Am J Obstet Gynecol       Date:  2019-02-01       Impact factor: 8.661

4.  The umbilical coiling index.

Authors:  T H Strong; D L Jarles; J S Vega; D B Feldman
Journal:  Am J Obstet Gynecol       Date:  1994-01       Impact factor: 8.661

5.  Does previa location matter? Surgical morbidity associated with location of a placenta previa.

Authors:  B C Young; A Nadel; A Kaimal
Journal:  J Perinatol       Date:  2014-01-30       Impact factor: 2.521

Review 6.  Placenta previa, placenta accreta, and vasa previa.

Authors:  Yinka Oyelese; John C Smulian
Journal:  Obstet Gynecol       Date:  2006-04       Impact factor: 7.661

7.  The placental factor in early- and late-onset normotensive fetal growth restriction.

Authors:  M Kovo; L Schreiber; A Ben-Haroush; G Cohen; E Weiner; A Golan; J Bar
Journal:  Placenta       Date:  2013-02-15       Impact factor: 3.481

Review 8.  Pathophysiology of Placenta Accreta Spectrum Disorders: A Review of Current Findings.

Authors:  Eric Jauniaux; Graham J Burton
Journal:  Clin Obstet Gynecol       Date:  2018-12       Impact factor: 2.190

9.  Risk factors of neonatal anemia in placenta previa.

Authors:  Dong Gyu Jang; Yun Sung Jo; Sung Jong Lee; Gui Se Ra Lee
Journal:  Int J Med Sci       Date:  2011-09-19       Impact factor: 3.738

10.  Maternal outcomes according to placental position in placental previa.

Authors:  Dong Gyu Jang; Ji Sun We; Jae Un Shin; Yun Jin Choi; Hyun Sun Ko; In Yang Park; Jong Chul Shin
Journal:  Int J Med Sci       Date:  2011-07-23       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.